Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
FDA safety review of Bluebird Bio gene therapy by end of 2024?  | Binary | 3 | 2 months ago | ||
New Bluebird Bio gene therapy trial announced by March 2025? | Binary | 3 | 2 months ago | ||
Bluebird Bio stock price rise over 10% by end of 2024? | Binary | 3 | 2 months ago | ||
FDA regulatory action on Bluebird Bio gene therapy by mid-2025? | Categorical | 3 | 2 months ago | ||
First major publication to report follow-up on Bluebird Bio therapy by end of 2024? | Categorical | 2 | 2 months ago | ||
Predominant outcome for Bluebird Bio therapy patients by end of 2025? | Categorical | 2 | 2 months ago |